260 related articles for article (PubMed ID: 2892451)
1. Antihistamines, drowsiness, and psychomotor impairment: central nervous system effect of cetirizine.
Gengo FM; Gabos C
Ann Allergy; 1987 Dec; 59(6 Pt 2):53-7. PubMed ID: 2892451
[TBL] [Abstract][Full Text] [Related]
2. Quantitative effects of cetirizine and diphenhydramine on mental performance measured using an automobile driving simulator.
Gengo FM; Gabos C; Mechtler L
Ann Allergy; 1990 Jun; 64(6):520-6. PubMed ID: 1971741
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system effects of H1-receptor antagonists in the elderly.
Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518
[TBL] [Abstract][Full Text] [Related]
4. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
[TBL] [Abstract][Full Text] [Related]
6. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
7. Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments.
García-Gea C; Martínez-Colomer J; Antonijoan RM; Valiente R; Barbanoj MJ
J Clin Psychopharmacol; 2008 Dec; 28(6):675-85. PubMed ID: 19011437
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of the peripheral and central effects of terfenadine and cetirizine 2 HCl.
Rihoux JP; Dupont P
Ann Allergy; 1987 Sep; 59(3):235-8. PubMed ID: 2888424
[TBL] [Abstract][Full Text] [Related]
9. Cetirizine effects on objective measures of daytime sleepiness and performance.
Seidel WF; Cohen S; Bliwise NG; Dement WC
Ann Allergy; 1987 Dec; 59(6 Pt 2):58-62. PubMed ID: 2892452
[TBL] [Abstract][Full Text] [Related]
10. The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine.
Gengo FM; Dabronzo J; Yurchak A; Love S; Miller JK
Clin Pharmacol Ther; 1987 Sep; 42(3):265-72. PubMed ID: 2887328
[TBL] [Abstract][Full Text] [Related]
11. Individual differences in central nervous system response to antihistamines (H1-receptor antagonists).
Simons FE; Fraser TG; Reggin JD; Simons KJ
Ann Allergy Asthma Immunol; 1995 Dec; 75(6 Pt 1):507-14. PubMed ID: 8603281
[TBL] [Abstract][Full Text] [Related]
12. A review of the effects of antihistamines on mental processes related to automobile driving.
Gengo FM; Manning C
J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):1034-9. PubMed ID: 1979799
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteers.
Kamei H; Noda Y; Ishikawa K; Senzaki K; Muraoka I; Hasegawa Y; Hindmarch I; Nabeshima T
Hum Psychopharmacol; 2003 Dec; 18(8):611-8. PubMed ID: 14696020
[TBL] [Abstract][Full Text] [Related]
14. Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists.
Witek TJ; Canestrari DA; Miller RD; Yang JY; Riker DK
Ann Allergy Asthma Immunol; 1995 May; 74(5):419-26. PubMed ID: 7749974
[TBL] [Abstract][Full Text] [Related]
15. Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use.
Tashiro M; Horikawa E; Mochizuki H; Sakurada Y; Kato M; Inokuchi T; Ridout F; Hindmarch I; Yanai K
Hum Psychopharmacol; 2005 Oct; 20(7):501-9. PubMed ID: 16086364
[TBL] [Abstract][Full Text] [Related]
16. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers.
Barbanoj MJ; García-Gea C; Morte A; Izquierdo I; Pérez I; Jané F
Neuropsychobiology; 2004; 50(4):311-21. PubMed ID: 15539863
[TBL] [Abstract][Full Text] [Related]
17. Objective antihistamine side effects are mitigated by evening dosing of hydroxyzine.
Goetz DW; Jacobson JM; Apaliski SJ; Repperger DW; Martin ME
Ann Allergy; 1991 Oct; 67(4):448-54. PubMed ID: 1683192
[TBL] [Abstract][Full Text] [Related]
18. Psychomotor and subjective effects of bilastine, hydroxyzine, and cetirizine, in combination with alcohol: a randomized, double-blind, crossover, and positive-controlled and placebo-controlled Phase I clinical trials.
García-Gea C; Martínez J; Ballester MR; Gich I; Valiente R; Antonijoan RM
Hum Psychopharmacol; 2014 Mar; 29(2):120-32. PubMed ID: 24395298
[TBL] [Abstract][Full Text] [Related]
19. Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance.
Theunissen EL; Vermeeren A; Ramaekers JG
Br J Clin Pharmacol; 2006 Jan; 61(1):79-86. PubMed ID: 16390354
[TBL] [Abstract][Full Text] [Related]
20. Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention (TOVA).
Mansfield L; Mendoza C; Flores J; Meeves SG
Ann Allergy Asthma Immunol; 2003 May; 90(5):554-9. PubMed ID: 12775138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
